Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple blood test could spot silent liver damage early

NCT ID NCT06119997

Recruiting now Knowledge-focused Sponsor: University Hospital, Grenoble Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a two-step screening method to find advanced liver fibrosis in people who don't yet have symptoms. First, a routine blood test calculates a score called FIB-4. If that score is high, patients get a more specialized non-invasive test. The goal is to see how well this approach works in primary care settings. About 500 adults aged 18–70 with no known hepatitis C infection will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this screening approach could help detect advanced liver fibrosis earlier in people without symptoms, potentially preventing progression to cirrhosis.
What could go wrong
This is an observational study, not a treatment trial. It only tests the screening process, so it won't directly improve health. The results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver fibrotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATIC FIBROSIS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Grenoble Alpes

    RECRUITING

    Grenoble, France

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.